Navigation Links
Playmaker

ProductsPlaymaker
Company DJO Incorporated
Item Playmaker
Features 
  • ACL and PCL versions feature patented 4-point dynamic leverage system
  • Low profile
  • Polycentric hinge with contoured condyle shells
  • Versatile strapping
  • Extension stops: 10, 20, 30 and 40 (10 installed)
  • Flexion stops: 45, 60, 75 and 90
  • Additional full-circumference thigh strap for CI conversion
    • Description Suitable for mild to moderate ACL and/or PCL, MCL and LCL instabilities, this neoprene brace with extended hinge bars is an ideal intermediate-level product that can be used in sporting activities. Click here to view more on this featured product.
    Info DJO Incorporated
    Customer Service: (888) 624-5450
    Web site: http://www.djortho.com/

    Related medicine products :

    1. Universal Handle for Blades
    2. Universal Trephine Handle with Cottingham Punch
    3. Storz Universal Trephine Handle
    4. Universal Conformer
    5. Universal Eye Shield - child
    6. Universal Eye Shield - adult
    7. Universal Goffman Blue Eye Garter Shield Cover and Blue Eye Shield
    8. Universal Trial Frames UB4
    9. Universal Folding Forcep
    10. Fine Universal II Inserter
    11. Panther Universal Spinal Retractor System
    TAG: Playmaker
    ...reatly improved with Volk's exclusive Double Asphe... precise and focused laser beam placement at the c...ng and laser treatment of the posterior capsule. T...indow for optimal laser beam transmission and imag...
    ...offers extremely high resolution treatment capabil...exceptionally wide 78° field of view. This len...f the optic nerve head and macula. Excellent stere...edesigned to reduce weight and size. High magnific...
    ...ent for critically evaluating and treating subreti...generation, retinal vascular occlusions, diabetic ...and other retinal conditions. It is ideal for foca...cellent magnification combined with a good field o...
    ...ns has grown in popularity since its introduction ...ens. Its sleek 28.6mm diameter housing provides a ...ses for peripheral retinal viewing, reflection dis... for small pupil fundus examination and as a gener...
    Medicine Products:
    (Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
    (Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
    (Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
    (Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
    Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
    ...month phase of a calorie-restriction study conduct... Center on Aging (USDA HNRCA) at Tufts University...hem in check may be an important component of weig... from the Comprehensive Assessment of the Long-ter...
    ... of your workout may metabolize more fat than exer...dy in Japan . Researchers conducted the first kno...cising continually in one long bout versus breakin...d. The findings could change the way we approach e...
    ...spond to drugs that combat the AIDS virus can see ...njoyed by people without HIV, a study published o...ds light on poorly understood conditions as to why... can boost and maintain their CD4 immune cells, ot...
    ...s, boasts of almost a thousand no-sex-till-marriag...rogram-Virginity Rules . Its brand ambassador bea...al abstinence for the group, which has risen from ...to become an eight-county abstinence franchise. P...
    Other Medicine News:Health News:Food Cravings are Linked to Weight Managenemt 2Health News:Food Cravings are Linked to Weight Managenemt 3Health News:Take a Break Inbetween Exercise 2Health News:Take a Break Inbetween Exercise 3Health News:HIV Drug Combo can Boost Immune Marker in Long-term Patients: Study 2Health News:Virginity Rules-Meant To Be Broken? 2Health News:Virginity Rules-Meant To Be Broken? 3
    (Date:10/2/2008)...ndicate Dual Modes of Action and Synergy with Chem...- Access Pharmaceuticals, Inc.,(OTC Bulletin Board...studies on Angiolix showing that by blocking lacta...t as well as a direct anti-proliferative effect on... breast cancer (MX-1),Angiolix had a significant ...
    (Date:10/1/2008)... the therapeutic potential of Amylin,s integrated ... pharmacotherapy, SAN DIEGO, Oct. 1 /PRNewswire-F... AMLN ) today announced that new data for its pip...2008 Annual Scientific Meeting of The,Obesity Soci...annual,meeting is one of the largest and most comp...
    (Date:10/1/2008)...(R) (zolpidem tartrate sublingual lozenge) develop... in the middle of the night when patients .... RICHMOND, Calif., Oct. 1 /- Transce...ty pharmaceutical company, announced today,that it... U.S. Food and,Drug Administration (FDA) for its l...
    (Date:10/1/2008)...l Study to Provide Real-World Dosing Simulation of...ibitor, INDIANAPOLIS, Oct. 1 /PRNewswire-FirstCal...nounced it will begin enrolling patients in a seco...inhibitor being investigated,as a potential treatm...lzheimer,s disease. The study, called IDENTITY 2, ...
    Breaking Medicine Technology:Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound 2Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound 3Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound 4Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound 5Has cancer spread 3F Research identifies best way to find answers so treatment can begin 24260 1Has cancer spread 3F Research identifies best way to find answers so treatment can begin 24260 2Tips from the Journals of the American Society for Microbiology 4145 1Tips from the Journals of the American Society for Microbiology 4145 2Tips from the Journals of the American Society for Microbiology 4145 3Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 1Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 2Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 3First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval 2679 1First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval 2679 2First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval 2679 3First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval 2679 4First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval 2679 5
    ...eting Also Showed No,Significant Impact on Weight ...ay 21, 2007 /PRNewswire-FirstCall/ --,Findings fro...,effect of desvenlafaxine succinate on anxious sym... with major depressive disorder,(MDD) -- as well a...ect of desvenlafaxine succinate on weight change i...
    ...in Risk of Hospitalization,from Crohn,s Disease vs...2007 /PRNewswire-FirstCall/ -- Abbott,today announ...study,presented at the Digestive Disease Week annu...th moderate to severely active,Crohn,s disease tre...py were almost 60 percent less likely than patient...
    Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 2New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 3New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 4New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 5New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 6New Analysis of Data Shows Treatment With Abbott's Humira,(Adalimumab) Significantly Reduced Disease-Related Hospitalization,for Patients with Crohn's Disease 7